Australian Critical Care

生成式人工智能只能用于改进写作的可读性和语言，需在人工监督下使用，作者须仔细审查和编辑结果，且该指引不适用于用AI分析数据。 模型中文摘要

The below guidance only refers to the writing process, and not to the use of AI tools to analyse and draw insights from data as part of the research process.Where authors use generative artificial intelligence (AI) and AI-assisted technologies in the writing process, authors should only use these technologies to improve readability and language. Applying the technology should be done with human ov…

所有作者须满足四项作者资格标准（参与研究设计或数据分析、撰写或修改稿件、批准最终版本、对工作负责），并须如实声明所有作者均已批准最终文章。 模型中文摘要

All authors should have made substantial contributions to all of the following: (1) the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work, AND (2) drafting the article or revising it critically for important intellectual content, AND (3) final approval of the version to be submitted, AND (4) agreement to be accountable for all aspects of the wor…

所有作者必须披露可能不当影响其工作的财务和个人关系，并在稿件末尾参考文献列表前提供利益声明摘要，无利益可声明时也须说明。 模型中文摘要

All authors must disclose any financial and personal relationships with other people or organisations that could inappropriately influence (bias) their work. Examples of potential competing interests include employment, consultancies, stock ownership, honoraria, paid expert testimony, patent applications/registrations, and grants or other funding. Authors must disclose any interests in two places:…

作者须提供伦理批准机构名称及批准号、参与者同意声明；若伦理批准被豁免或不需要，须提供相关细节和解释，且豁免决定不能由作者自行确定。 模型中文摘要

Please ensure you provide the name of the institution providing ethical approval and any relevant approval numbers. Where multiple approvals have been obtained, it is sufficient to provide the details from the initial approving institution. Please also include a statement for participant consent. If ethical approval has been waived or is not required in your jurisdiction, please provide relevant d…

文章被接受后，作者须填写'期刊出版协议'，使出版商代表作者和学会管理版权，同时允许作者继续将材料用于学术交流。 模型中文摘要

Upon acceptance of an article, authors will be asked to complete a 'Journal Publishing Agreement' (for more information on this and copyright see https://www.elsevier.com/copyright). This enables the Publisher to administer Copyright on behalf of the Authors and the Society, whilst allowing the continued use of the material by the Author for Scholarly communication. An e-mail will be sent to the c…

作者可选择是否以开放获取方式发表论文，澳大利亚重症监护护士学会会员可享受开放获取出版费20%的折扣。 模型中文摘要

Authors can choose whether to publish their paper as open access. There is a 20% discount off the open access publication fee for members of the Australian College of Critical Care Nurses (the College). Please visit our open access page for more information and pricing. Learn more about Elsevier's pricing policy: https://www.elsevier.com/openaccesspricing.

本期刊采用单盲同行评审，投稿时须包含识别信息（如临床试验注册号、伦理批准机构名称和批准号、作者姓名首字母、作者既往发表文献引用），稿件由至少两名独立专家评审。 模型中文摘要

This journal operates a single-blind peer review process. Identifying information such as Clinical Trials Numbers, names of institutions providing ethical approval (and any relevant ethical approval numbers), author initials, citations to author's previous publications should be included in the initial submission.All contributions will be initially assessed by the Editor-in-Chief for suitability f…

预印本可随时在任何地方共享，在预印本服务器上共享预印本不算作先前发表，但投稿时须提供预印本信息（包括DOI）。 模型中文摘要

Preprints can be shared anywhere at any time, in line with Elsevier's sharing policy. Sharing your preprints e.g. on a preprint server will not count as prior publication (see 'Multiple, redundant or concurrent publication' for more information). Information regarding the preprint, including the DOI must be included during submission.Elsevier supports responsible sharingFind out how you can share …

根据ICMJE建议，在公共临床试验注册库注册是本期刊发表临床试验的条件。 模型中文摘要

Registration in a public trial registry is a condition for publication of clinical trials in this journal in accordance with International Committee of Medical Journal Editors (ICMJE, https://www.icmje.org) recommendations.